You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 9, September 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Cognitive Disorders
 •Neuropathology
 •Alert me on articles by topic

Error in Text in: Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease

Arch Neurol. 2007;64(9):1246.

Error in Text. In the Original Contribution by Graff-Radford et al titled "Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease," published in the March issue of the Archives (2007;64[3]:354-362), an error occurred in the "Methods" section on page 356. In the subsection titled "Method of Measuring Plasma Aβ40 and Aβ42 Levels," the fourth sentence should have read as follows: "Plasma Aβ measures were made using an enzyme-linked immunosorbent assay method with the well-characterized antibodies BAN-50/BA27 specific for Aβ40 and BNT-77/BC05 specific for Aβ42.9"







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.